Radiation Oncologists

clinican_outline

 

Dr Angela Hong MBBS, MMed, PhD, FRANZCR


Dr Hong is a radiation oncologist at Royal Prince Alfred hospital. Angela graduated from the University of Sydney in 1994. During 1996-1997, she performed laboratory research on radiosensitivity at the Memorial Sloan Kettering Cancer Center, New York and the University of Davis, California. This research culminated in Angela being awarded the Master of Medicine degree from University of Sydney in 1998. In 2001 she was awarded the fellowship of the Royal Australian and New Zealand College of Radiologists and was the recipient of the Kaye Scott Prize. Her research interests continued at the Radiation Biology laboartory at the Royal Prince Alfred hospital, forming the basis of her PhD, which was awarded in 2004 by the University of Sydney. Her clinical interests include management of melanoma & skin malignancy, haematological malignancy, bone & soft tissue tumour and radiosensitivity.

clinican_outline

 

Dr George Hruby BHB, MBChB, FRANZCR

Dr Hruby has been a staff specialist at RPA and Concord Hospitals since December 2000.  His areas of interest include gastrointestinal and genito-urinary cancers as well as melanoma and merkel cell cancer, as well as education and consumer advocacy.

At RPA Dr Hruby has established a high dose rate brachytherapy program for the treatment of prostate cancer.

Dr Hruby is a Senior Clinical Lecturer at the University of Sydney, and has lectured, taught and published in the various facets of his work.

Dr_Gerald_Foggarty

Dr Gerald Fogarty


Dr Fogarty is a consultant radiation oncologist who works at Mater and St Vincent’s Sydney Hospitals.  He is the Director of the Mater Radiotherapy Centre and attends multidisciplinary clinics for cancers arising from skin, head and neck, CNS, urological and lung tissues.  Gerald trained at Peter MacCallum Cancer Institute, Australia’s largest cancer centre. He has over 21 first author publications and is the principal investigator of an NH & MRC International Phase III Trial in radiotherapy in melanoma. Gerald is also a senior lecturer at both the University of Sydney and University of NSW.